#Diabetes Awareness #Health Alerts #Medical Innovations

Weekly Health Press Release Recap

In the fast-paced world of healthcare, it's crucial to stay updated with the latest developments that can impact patients and professionals alike. Each week, thousands of press releases unleash a torrent of information. To simplify this process for healthcare journalists and consumers, we have compiled a selection of noteworthy releases from the past week. Below are some highlights from the week of March 24-28, 2025, showcasing essential updates that should not be overlooked.

1. Diabetes Alert Day: Know Your Risk

Nearly half of Americans face diabetes or prediabetes challenges. Charles Henderson, CEO of the American Diabetes Association, emphasizes the importance of understanding risks and symptoms. The call to action encourages individuals to consult healthcare professionals if they have concerns.

2. National Resident Matching Program® Results

The 2025 Main Residency Match saw a total of 52,498 applicants registered, marking a 4.1% increase from the previous year. This event signifies the beginning of their medical training, setting the stage for the next generation of physicians.

3. Novo Nordisk Expands Wegovy® Savings Offer

The company has made Wegovy® available at $499 per month for cash-paying patients and those with insurance that excludes obesity medications. This initiative aims to increase accessibility for patients battling obesity.

4. Introducing Spatial Computing in Healthcare

Endo has launched a Spatial Computing Injection Simulator, which merges physical and digital learning aids. This simulator will empower hand specialists by refining their injection techniques, potentially transforming training methodologies.

5. The Silent Epidemic of Adverse Drug Events

Recent studies reveal that adverse drug reactions (ADRs) are the third leading cause of death, with over 94% remaining unreported by healthcare practitioners. This highlights the urgent necessity for improved reporting systems to detect safety signals.

6. Pharmaceutical Innovation Report by Deloitte

Deloitte's 15th annual report indicates a promising upward trend in pharmaceutical R&D returns for the second consecutive year, largely driven by the development of GLP-1 therapies—critical in addressing significant healthcare needs.

7. Advancements in Cardiovascular Care

Abbott is initiating new clinical trials for its Intravascular Lithotripsy System, which utilizes sound waves to alleviate arterial calcium blockages, potentially revolutionizing treatment for coronary artery disease.

8. CiVax™ Booster Shows Promise Against COVID-19 Variants

Research by Soligenix demonstrates that a CiVax™ booster alongside the AstraZeneca primary vaccine enhances protection against various COVID-19 variants, outpacing traditional two-dose mRNA vaccine regimens.

9. Funding to Combat Substance Use Disorders

Tempero Bio secured $70 million in Series B financing to further its TMP-301 therapy, which targets the biology of addiction and aims to support relapse prevention through crucial phase 2 trials.

10. Collaboration for Skin Cancer Awareness

Pro-gamer Tyler